Chamber and committees

I refer the member to the answer to the question S6W-36412 on 29 April 2025. All answers to written Parliamentary Questions are available on the Parliament’s website, the search facility for which can be found at https://www.parliament.scot/chamber-and-committees/written-questions-and-answers

The NHS in Scotland holds data on the prescribing of diethylstilbestrol (otherwise known as DES or stilbestrol) in both primary care and secondary care.

Data on primary care usage of medicines is published and available on the Public Health Scotland website Show all releases - Publications - Public Health Scotland. Data on secondary usage is not routinely published.

The Scottish Government is not aware of any actions to investigate the reported number of people exposed to diethystilbesterol (also known as DES or stilbesterol).

The regulation for the licensing, safety and efficacy of medicines is reserved to the UK Government and is the responsibility of the Medicines and Healthcare products Regulatory Agency (MHRA).

Action 1:1 of our Health Visiting Action Plan 2025-2035, the establishment of an online health visiting site, is scheduled for completion by the end of 2025.

Scottish Government notes this report with interest and is fully aware that the risk of liver disease is increased by the impact of harmful alcohol use and obesity.

This is why we are determined to do all we can to reduce alcohol-related harm, one of the most pressing public health challenges that we face in Scotland. We take a whole population approach to tackling such harm, in line with the World Health Organisation’s focus on affordability, availability and attractiveness of alcohol.

Our Alcohol Framework 2018 contains 20 actions to tackle alcohol-related harm. One of the key actions was the implementation of Minimum Unit Pricing (MUP) in May 2018. Since then, we have seen a reduction of 3% in total alcohol sales,with a focus on the cheap high-strength alcohol which is often drunk by people drinking at harmful levels. Recent research by Public Health Scotland has found that MUP has been found to save more than 150 lives a year and 411 fewer hospital admissions. It’s also encouraging to see that this research has highlighted that the policy is having an effect in Scotland’s most deprived areas – which experience higher death rates and levels of harms from problem alcohol.

We also want everyone in Scotland to eat well and have a healthy weight to help reduce the impact of a range of diet-related ill health conditions, including liver disease. We continue to implement the wide-ranging actions set out in our 2018 Diet and Healthy Weight Delivery Plan to address this challenge. This includes our commitment to restrict less healthy food promotions and improve the availability of healthier options when eating out, as outlined in our Out Of Home Action Plan.

Scottish Government through its national Centre for Sustainable Delivery (CfSD) has formed a Specialty Delivery Group for Liver Disease with the first meeting on 6th November 2024. Early Detection is one of the pathways being prioritised.

The Early Detection Pathway has already been passed through the first Gateway in the CfSD delivery pathway. The challenges are around how individual boards can implement this before the National Laboratory Information Management System.

There has been progress in developing the Early Detection pathways in individual health boards using the technology as currently available while others are using the Referral Advice to Primary Care with increased use of the FIB-4 and Fibroscan with advice for Lifestyle changes and repeat investigation as required.

The Scottish Government understands the important role that sport and leisure services play in improving people’s lives, and the physical, mental, and social health benefits they can bring.

The Scottish Government recognises the financial challenges that local government are facing and that local authorities and their employees play a crucial role in communities and that is why the 2025-26 Scottish Budget provides record block grant funding of over £15.1 billion for local government, an increase of £1.1 billion or 5.5 per cent in real terms compared to 2024-25.

In 2025-26, Glasgow City Council will receive over £1.8 billion to support day to day services and capital investment plans, which equates to an extra £96.8 million or an additional 5.5% compared to 2024-25. In addition, all Councils will receive their fair share of the currently undistributed sum of £245 million and £144 million allocated for employers' National Insurance Contributions.

While it is for local authorities to manage their own budgets and to allocate the total financial resources available to them on the basis of local needs and priorities, we will work together to find collective solutions about issues that matter to the people of Scotland.

Screening policy in Scotland is based on recommendations from the UK National Screening Committee (UK NSC), an expert advisory group which advises the UK nations on all aspects of screening. The UK NSC reviewed the starting age for cervical screening in 2013 and recommended it should be increased from 20 to 25. The Scottish cervical screening programme therefore offers routine screening to women and people with a cervix who are aged between 25 and 64.

Since 2008, the HPV vaccination has also been offered to women under 25, which provides immunity to the virus that causes the majority of cases of cervical cancer. No cervical cancers have been found in those vaccinated in Scotland.

Nonetheless, in August 2021, the then Minister for Public Health and Women’s Health, Maree Todd, wrote to the UK NSC to ask them to keep the merits of lowering the age for cervical screening under review. To date, the evidence continues to support cervical screening beginning at the age of 25; a study found that for every 100,000 women invited for screening from the age of 20, an extra 8,000 women would need further investigation and 3,000 more would have unnecessary and potentially harmful treatment.

Provision of medical first aid at a major sporting event is the event organisers’ responsibility which, in this instance, is the Glasgow 2026 Organising Company.

The Scottish Government continues to work closely with event organisers to ensure that Scottish Ambulance Service, NHS Boards and Public Health Scotland are appropriately engaged in planning groups for major sporting events.

Public sector health colleagues work meticulously with the event organisers and any procured private first aid and ambulance services to ensure adequate first aid and health care is provided to event participants, workforce and spectators, in line with guidance and requirements as set out in the Green and Purple Guides.

The Green Guide, or ‘Guide to Safety at Sports Grounds’, provides guidance on safety at sports grounds for stadium operators and event organisers. The Purple Guide is aimed at event organisers who are responsible for managing health and safety and at events in more general terms.

In response to the Manchester Arena Inquiry the Terrorism (Protection of Premises) Act received royal assent on Thursday 3rd April 2025 and has a 24 month commencement period before it will come into force.

The Scottish Government continues to work in collaboration with the UK Government in the development of Statutory Guidance that will support the legislation. The Scottish Government will consider how the regulation of ambulances and first aid provision in Scotland needs to align with the Terrorism (Protection of Premises) Act as this guidance is developed and in response to the views of stakeholders.

The Scottish Government continues to encourage and signpost stakeholders to both the Protect UK and Gov.UK websites for further information and updates on the legislation. Materials and guidance to support duty holders is available on both websites over the commencement period.

The 2025-26 Budget will provide a record £21.7 billion for Health and Social Care, including almost £200 million to reduce waiting lists and improve flow through hospitals. Gynaecology will be targeted as a key priority area for additional funding.

We are committed to ensuring those living with endometriosis are able to access the best possible care and support and that they benefit from healthcare services that are safe, effective and put people at the centre of their care.

Endometriosis is one of the key priorities in the Women’s Health Plan and will continue to be so. Timely access to gynaecology services will also be a priority as we continue to develop the next phase of our Women’s Health Plan, which we aim to publish in 2025.